{
    "medicine_id": "e6e3adb6da8c42f10360f90e68ea908629fe7cf5",
    "platform_id": "DB05087",
    "metadata": {
        "name": "Tymlos 2000 ug 1mL Injection solution",
        "composition": "2000 ug 1mL Ganaxolone",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in pediatric indications and seizure disorders",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Ganaxolone is a powerful positive allosteric modulator of GABAA receptors with potency and efficacy comparable to its endogenous analog 3a 5a P Carter et al 1997 As with 3a 5a P Ganaxolone potentiation of the GABAA receptor occurs at a site distinct from the benzodiazepine site Ganaxolone has protective activity in diverse rodent seizure models including clonic seizures induced by pentylenetetrazol PTZ and bicuculline BIC limbic seizures in the 6 Hz model and amygdala kindled seizures Carter et al 1997 Rogawski and Reddy 2004 Kaminski et al 2004",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}